Salim Yusuf OC FRSC (born 26 November 1952) is an Indian-born Canadian physician, the Marion W. Burke Chair in Cardiovascular Disease at McMaster University Medical School.
[2] Following a number of failed attempts, Yusuf studied medicine at St. John's Medical College in Bangalore.
[3][2] His doctoral thesis was titled "Beta adrenergic blockade in myocardial infarction" and his supervisor was Peter Sleight.
[4] In 1984, Yusuf moved to the National Institutes of Health in the United States, where he led clinical trials that showed the value of ACE inhibitors in people with left ventricular dysfunction and the optimal use of digoxin).
Yusuf's large-scale clinical trials have had a significant impact on the treatment and prevention of cardiovascular and cerebrovascular disease.
He was a past president of the World Heart Federation 2015–2016,[8] where he initiated the Emerging Leaders Program which is now named after him.
[10] In 2017, Yusuf spoke at the Cardiology Update 2017 symposium in which he disputed the saturated fat guidelines whilst admitting he is not an expert in nutrition.